GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma

NCT05178043 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma
HCC

Interventions

DRUG: Nivolumab
DRUG: GT90001

Sponsor

Suzhou Kintor Pharmaceutical Inc,